The US Food and Drug Administration (FDA) has released a new public advisory related to potential side effects of the COVID-19 vaccine to those with rare heart conditions–myocarditis and pericarditis.
The new advisory follows the latest clinical research, which indicates a higher chance of these side effects and the need for mRNA vaccine manufacturers to include this information in their prescribing information for patients.
